# Meet Beth Hicks > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/meet-beth-hicks/ > **Published:** 2026-07-21T07:10:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-09T10:03:30-04:00 > **Clinical Summary:** Clinician guide to cannabis mental health treatment: evidence, risk assessment, and diagnostic considerations for comprehensive psychiatric care. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. [Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/)AnxietyCBDTHCSafetyResearchPolicy Dr. Caplan’s Take I appreciate Beth’s advocacy for integrated [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) care, though I’d note that while we have growing observational data suggesting some patients report symptom relief with cannabis, we still lack the rigorous randomized controlled trials in psychiatric populations that would let me prescribe with the same confidence I have for, say, managing hypertension. The early signals are worth watching, but we need to be cautious about positioning cannabis as a first-line [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) tool when evidence-based psychotherapy and FDA-approved medications remain our foundation. Clinical Perspective 💊 While patient testimonials like Beth Hicks’ advocacy for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) in mental health treatment highlight the growing public interest and perceived benefits, clinicians should remain cautiously measured in their approach given the limited high-quality evidence for cannabis efficacy in psychiatric conditions compared to established pharmacotherapies. The heterogeneity of cannabis products (varying cannabinoid ratios, THC concentrations, and administration routes), individual variability in metabolism and response, and potential risks including psychosis exacerbation in vulnerable populations complicate [clinical decision-making](https://cedclinic.com/cannabinoids-mental-health-systematic-review-evidence-insights/). Additionally, cannabis’s legal status in many jurisdictions creates barriers to rigorous research and [clinical oversight](https://cedclinic.com/cannabis-clinical-oversight-seniors-relief-safety/), leaving significant gaps in our understanding of long-term psychiatric outcomes and [drug interactions](https://cedclinic.com/cannabis-liver-interactions-study-insights/). For practitioners encountering patients interested in cannabis for mental health, the clinical implication is to engage in shared decision-making that acknowledges the patient’s perspective while emphasizing the need for evidence-based first-line treatments, careful psychiatric screening, 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Meet%20Beth%20Hicks%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70919)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70919)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Meet%20Beth%20Hicks%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70919)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://boldjourney.com/meet-beth-hicks/](https://boldjourney.com/meet-beth-hicks/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).